By Reeve Hamilton On Tuesday, the U.S. Supreme Court ruled, with a vote of 6-2, that vaccine manufacturers are protected from lawsuits by parents who believe that vaccines harmed their children. One thing this assuredly means for Texas: The anti-immunization community will be out in force this session working against vaccine mandates — including a […]
Archives for February 2011
Virus-mimic 'paves way for vaccine'
From The Press Association Artificial particles which resemble virus material could form the basis of super-efficient vaccines, new research has suggested. The nanoparticles have already been used to protect mice and monkeys against flu. Scientists now hope to develop hybrid natural-synthetic vaccines that can prevent serious infections for a lifetime. The experimental vaccine consists of […]
MIT tests new nanoparticle for vaccine delivery
By Ryan McBride While there’s been some progress to make synthetic vaccines for HIV that avoid the dangers of using the virus itself to spur the body’s defenses, delivering the synthetic vaccines with existing technology hasn’t elicited the desired immune responses. MIT researchers might have found one way to overcome this delivery challenge—a new nanoparticle […]
Extending vaccine benefits to developing world will require innovation
Pediatric SuperSite
May 4, 2010
VANCOUVER, British Columbia — Creative vaccine distribution strategies, improved vaccine technologies and more rapid manufacturing timetables were among ideas speakers at the 2010 Pediatric Academic Societies proposed during a symposium on vaccine-preventable diseases in the developing world.
Kathleen M. Neuzil, MD, MPH, professor of medicine at the University of Washington, senior advisor for immunizations at PATH, both in Seattle, and Advisory Committee on Immunization Practices member said that the lessons learned during this past season’s influenza A (H1N1) pandemic can be applied to distributing vaccines to people in low-resource settings.
CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer
Chatterjee K, Williamson AL, Hoffman M, Dandara C. Division of Medical Virology and Institute of Infectious Disease and Molecular Medicine (IIDMM), University of Cape Town, Cape Town, Republic of South Africa. Abstract Only a small fraction of women infected with human papillomavirus (HPV) progress to cervical cancer pointing to additional risk factors including host genetics […]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 52
- Next Page »